2. Confirmed diagnosis of B-cell Non-Hodgkin's lymphoma limited to follicular lymphoma (FL), DLBCL, mantle cell lymphoma (MCL), marginal zone lymphoma (MZL) or CLL/SLL that has progressed and for which standard curative measures do not exist or are no longer effective. Prior therapy must have included a rituximab-based regimen.